US biotech Beam Therapeutics released early-stage data on its sickle cell disease candidate BEAM-101. Also of note, Arcus Biosciences and Gilead ...
News
- The week in pharma: action, reaction and insight – week to November 8 | Pharmaceutical
- UTSA students helping veterans with engineering and tech projects - San Antonio Express-News
... San Antonio who are designing and building a lift that will help him ... Abhinaya “Abhi” Lakkureddi, a junior studying biomedical engineering ...
- Lyell Immunopharma: Q3 Earnings Snapshot - MySA
The biotechnology firm posted revenue of $34,000 in the period. ... San Antonio area. Nov 7, 2024 ... San Antonio News · Councilman Marc Whyte pleads ...
- Anixa Biosciences and Cleveland Clinic Present New Updated Positive Data from Phase 1 ...
(“Anixa” or the “Company”) (NASDAQ: ANIX), a biotechnology ... Initial Phase 1 data was presented at the San Antonio Breast Cancer Symposium in December ...
- Sana: Q3 Earnings Snapshot - MySA
Early voting in San Antonio has seen a record number of voters eager to cast their.